{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-237643","form_type":"8-K","ticker":"IFF","cik":"0000051253","company_name":"INTERNATIONAL FLAVORS & FRAGRANCES INC","filed_at":"2023-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.378813+00:00","generated_at":"2026-06-10T14:10:25.008191+00:00","sec_items":["1.01","2.03","7.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"IFF amends credit agreements, extends covenant relief through Dec 2025; reiterates FY2023 guidance","bullets":["Term loan and revolver covenants eased: leverage ratio steps down from 5.25x to 3.75x by Dec 2025.","Dividends capped at $0.81/share/quarter; loan margins increase 0.125% during relief period.","FY2023 sales guidance $11.3B–$11.6B; adjusted operating EBITDA $1.85B–$2.0B.","Pursuing sale of Cosmetic Ingredients business (Lucas Meyer Cosmetics) plus additional divestitures.","Aims for net debt to credit adjusted EBITDA below 3x by end of 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-237643","json":"https://secwatch.observer/filing/0001193125-23-237643.json","markdown":"https://secwatch.observer/filing/0001193125-23-237643.md","text":"https://secwatch.observer/filing/0001193125-23-237643.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/51253/000119312523237643/0001193125-23-237643-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/51253/000119312523237643/d549681d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T14:10:25.008191+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"810ec52e251890f37b5503245fedd3be7bd7066d","claim":"INTERNATIONAL FLAVORS & FRAGRANCES INC amended Amendment No. 4 to Revolving Credit Agreement with Citibank, N.A. valued at Extends financial covenant relief period through Dec 31, 2025; leverage ratio thresholds from 5.25:1 (effective 2023-09-19).","evidence_excerpt":"On September 19, 2023, the Company and certain of its subsidiaries (collectively, the “Loan Parties”) entered into Amendment No. 4 (the “Revolver Amendment”) to amend that certain Third Amended and Restated Credit Agreement, dated July 28, 2021 (as amended by that certain Amendment No. 1 to Credit Agreement, dated August 4, 2022, as further amended by that certain Amendment No. 2 to Credit Agreement, dated as of March 23, 2023, as further amended by that certain Amendment No. 3 to Credit Agreement, dated as of March 23, 2023, the “Existing Revolving Credit Agreement”, and the Existing Revolving Credit Agreement, as amended by the Revolver Amendment, the “Revolving Credit Agreement”), among the Loan Parties, the lenders party thereto and Citibank, N.A., as administrative agent.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/51253/000119312523237643/0001193125-23-237643-index.htm","confidence":0.99,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Citibank, N.A."},{"label":"Value","value":"Extends financial covenant relief period through Dec 31, 2025; leverage ratio thresholds from 5.25:1"},{"label":"Effective","value":"2023-09-19"}],"fact_type":"material_agreement"},{"claim_id":"ffd4a2b7e5a8486086adc0916bad1dfb2365f21e","claim":"INTERNATIONAL FLAVORS & FRAGRANCES INC amended Amendment No. 5 to Term Loan Credit Agreement with Morgan Stanley Senior Funding, Inc. valued at Extends financial covenant relief period through Dec 31, 2025; leverage ratio thresholds from 5.25:1 (effective 2023-09-19).","evidence_excerpt":"On September 19, 2023, International Flavors & Fragrances Inc. (the “Company”) entered into Amendment No. 5 (the “Term Loan Amendment”) to amend that certain term loan credit agreement, dated January 17, 2020 (as amended by that certain Amendment No. 1 to Credit Agreement, dated as of August 25, 2020, as further supplemented by that certain Icon Debt Assumption Supplement, dated as of March 4, 2021, as further amended by that certain Amendment No. 2 to Credit Agreement, dated as of August 4, 2022, as further amended by that certain Amendment No. 3 to Credit Agreement, dated as of March 23, 2023, as further amended by that certain Amendment No. 4 to Credit Agreement, dated as of March 23, 2023, the “Existing Term Loan Credit Agreement”, and the Existing Term Loan Credit Agreement, as amended by the Term Loan Amendment, the “Term Loan Credit Agreement”), among the Company (as successor to Nutrition & Biosciences, Inc.), the lenders party thereto and Morgan Stanley Senior Funding, Inc., a","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/51253/000119312523237643/0001193125-23-237643-index.htm","confidence":0.99,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Morgan Stanley Senior Funding, Inc."},{"label":"Value","value":"Extends financial covenant relief period through Dec 31, 2025; leverage ratio thresholds from 5.25:1"},{"label":"Effective","value":"2023-09-19"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}